A multi-peptide blend combining GHK-Cu (50 mg), TB-500 (10 mg), BPC-157 (10 mg), and KPV (10 mg) for research exploring synergistic activity across tissue repair and immune signaling pathways. This formulation adds immune modulation via KPV alongside the tissue repair compounds.
KLOW is a multi-peptide blend that combines GHK-Cu (50 mg), TB-500 (10 mg), BPC-157 (10 mg), and KPV (10 mg) into a single research formulation. In laboratory settings, it is used to examine how peptide systems associated with copper transport, vascular signaling, extracellular matrix activity, cell migration, and skin-related pathway regulation may function together within the same experimental model.
KLOW is studied through the combined pathway activity of its four components. GHK-Cu is commonly examined for copper-binding and extracellular matrix-related signaling, TB-500 for actin dynamics and cell-migration biology, BPC-157 for angiogenic and nitric oxide-related pathway activity, and KPV as an alpha-MSH–derived tripeptide fragment used in inflammatory and epithelial pathway research. As a blend, it is commonly used in studies involving connective tissue biology, vascular signaling, dermal pathway models, extracellular matrix dynamics, cell migration, and coordinated multi-peptide signaling research.
KLOW reflects the broader use of multi-peptide blends in laboratory research, where several well-known peptide systems are combined into a single formulation for coordinated pathway analysis. Vendor descriptions consistently present KLOW as a blend of GHK-Cu, TB-500, BPC-157, and KPV rather than as a single new standalone compound with one unified chemical identity.
For research use only. Not for human or veterinary use. Detailed storage guidelines →